High-risk chronic lymphocytic leukemia in the era of pathway inhibitors: integrating molecular and cellular therapies

Peter Dreger*, Paolo Ghia, Johannes Schetelig, Michel van Gelder, Eva Kimby, Mauricette Michallet, Carol Moreno, Tadeusz Robak, Stephan Stilgenbauer, Emili Montserrat, ERIC; European Soc Blood Marrow

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)892-902
Number of pages11
JournalBlood
Volume132
Issue number9
DOIs
Publication statusPublished - 30 Aug 2018

Keywords

  • VERSUS-HOST-DISEASE
  • GCLLSG CLL3X TRIAL
  • MARROW TRANSPLANTATION
  • OPEN-LABEL
  • FOLLOW-UP
  • ALLOGENEIC TRANSPLANTATION
  • CLONAL EVOLUTION
  • EUROPEAN-SOCIETY
  • RICHTER TRANSFORMATION
  • RETROSPECTIVE ANALYSIS

Cite this